ZZ Biotech has been developing 3K3A-APC, a genetically engineered variant of human activated protein C (APC), a serine protease, that has been optimized for human therapeutic use. The company is pleased to announce it has agreed in principle to license its 3K3A-APC program in dermatology to Dermatherix, Pty Ltd. Dermatherix is a pioneering biotech company dedicated to advancing wound therapies through innovative research. ZZ Biotech is excited to see its drug 3K3A-APC advanced by the team at Dermatherix.
Company Details
- Employees
- 14
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://zzbiotech.com/
Zz Biotech Questions
Zz Biotech's website is http://zzbiotech.com/
Zz Biotech's LinkedIn profile is https://www.linkedin.com/company/zz-biotech
Zz Biotech has
14 employees.
View email and phone details for 14
employees at Zz Biotech.
Zz Biotech's industry is
Pharmaceutical Manufacturing
Zz Biotech's categories are Pharmaceutical Manufacturing
Zz Biotech's founding year is 2006
